So-Young International (SY) EBITDA (2017 - 2025)
So-Young International (SY) EBITDA from Dec 31, 2017 to Dec 31, 2025. The TTM So-Young International (SY) EBITDA is -$33M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
So-Young International (SY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -58.69% |
| 3 Years | +59.44% |
| 5 Years | +38.06% |
Annual EBITDA change of So-Young International (SY)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$33M | -58.69% |
| 2024 | -$79M | +3660.63% |
| 2023 | -$2.11M | -73.91% |
| 2022 | -$8.08M | +1961.00% |
| 2021 | -$392K | -94.00% |
| 2020 | -$6.53M | -130.04% |
| 2019 | $22M | +194.15% |
| 2018 | $7.39M | +89.47% |
| 2017 | $3.90M | N/A |
Comparison So-Young International (SY) five years EBITDA CAGR with competitors
So-Young International (SY) five years EBITDA CAGR is 39.98%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | +94.41% |
| CCLD | CareCloud Inc | 73.90% | +84.85% |
| CCLDO | CareCloud Inc | 73.90% | +84.85% |
| DOCS | Doximity Inc - Class A | 32.10% | -19.71% |
| HQY | Healthequity Inc | 26.05% | -34.83% |
| VEEV | Veeva Systems Inc - Class A | 25.30% | -36.72% |
| HCAT | Health Catalyst Inc | 20.13% | -49.64% |
| SDGR | Schrodinger Inc | 18.03% | -54.90% |
| PRVA | Privia Health Group Inc | 10.68% | -73.30% |
| EVH | Evolent Health Inc - Class A | 9.64% | -75.89% |
| SOPH | SOPHiA Genetics SA | 9.33% | -76.67% |
| HSTM | Healthstream Inc | 9.04% | -77.39% |
| OMCL | Omnicell Inc | 0.63% | -98.43% |
| DRIO | DarioHealth Corp | 0.22% | -99.45% |